key: cord-0308168-rnfh9v1h
authors: Kang, M.; Xin, H.; Yuan, J.; Ali, S. T.; Liang, Z.; Zhang, J.; Hu, T.; Lau, E.; Zhang, Y.; Zhang, M.; Cowling, B. J.; Li, Y.; Wu, P.
title: Transmission dynamics and epidemiological characteristics of Delta variant infections in China
date: 2021-08-13
journal: nan
DOI: 10.1101/2021.08.12.21261991
sha: a16536c5d0c399966381b3563743e87e5fa36fa4
doc_id: 308168
cord_uid: rnfh9v1h

Background: The Delta variant of SARS-CoV-2 has become predominant globally. We evaluated the transmission dynamics and epidemiological characteristics of the Delta variant in an outbreak in southern China. Methods: Data on confirmed cases and their close contacts were retrospectively collected from the outbreak that occurred in Guangdong, China in May-June 2021. Key epidemiological parameters, temporal trend of viral loads and secondary attack rates were estimated and compared between the Delta variant and the wild-type SARS-CoV-2 virus. We also evaluated the association of vaccination with viral load and transmission. Results: We identified 167 patients infected with the Delta variant in the Guangdong outbreak. The mean estimates of the latent period and the incubation period were 4.0 days and 5.8 days, respectively. A relatively higher viral load was observed in Delta cases than in wild-type infections. The secondary attack rate among close contacts of Delta cases was 1.4%, and 73.9% (95% confidence interval: 67.2%, 81.3%) of the transmissions occurred before onset. Index cases without vaccination (OR: 2.84, 95% confidence interval: 1.19, 8.45) or with one dose of vaccination (OR: 6.02, 95% confidence interval: 2.45, 18.16) were more likely to transmit infection to their contacts than those who had received 2 doses of vaccination. Discussion: Patients infected with the Delta variant had more rapid symptom onset. The shorter and time-varying serial interval should be accounted in estimation of reproductive numbers. The higher viral load and higher risk of pre-symptomatic transmission indicated the challenges in control of infections with the Delta variant.

CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 and 5.8 days, respectively. A relatively higher viral load was observed in Delta cases than in 48 wild-type infections. The secondary attack rate among close contacts of Delta cases was 1.4%, 49 and 73.9% (95% confidence interval: 67.2%, 81.3%) of the transmissions occurred before 50 onset. Index cases without vaccination (OR: 2.84, 95% confidence interval: 1. 19, 8.45) or 51 with one dose of vaccination (OR: 6.02, 95% confidence interval: 2.45, 18.16) were more 52 likely to transmit infection to their contacts than those who had received 2 doses of 53 vaccination. 54

Discussion: Patients infected with the Delta variant had more rapid symptom onset. The 55

shorter and time-varying serial interval should be accounted in estimation of reproductive 56 numbers. The higher viral load and higher risk of pre-symptomatic transmission indicated the 57 challenges in control of infections with the Delta variant. 58 59 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 

6 Comprehensive large-scale nucleic acid-testing strategies, including community-wide PCR 110 testing, routine test among concentrated quarantine close contacts and daily test for inpatients, 111 were implemented in every local COVID-19 outbreak in China since April 2020 (6). For each 112 case, serial samples were collected and tested for both N-gene and OR-gene from the date of 113 first positive PCR test until discharge from hospital. To understand the temporal dynamics of 114 viral RNA shedding for the Delta variant, we obtained serial cycle threshold (Ct) values for 115 each case for N-gene with throat swabs from the first time of positive test (Ct value <40). To 116 make a comparison of viral loads between the Delta variant and the wild-type variant, we 117 used data of wild-type SARS-CoV-2 infections that were identified in Guangzhou, China in 118 early 2020 from a published paper on individual cases with daily test results (7). 119 120

A patient is confirmed as a COVID-19 case based on a positive result of PCR for SARS-122

CoV-2 with respiratory specimens. Virus strains in this study were determined by the 123 sequenced genome and were classified based on the "Pango lineages" rule (8). The time 124 interval between infection and becoming infectious is defined as the latent period, that could 125 be compared with the incubation period which describes the time duration between infection 126 and symptom onset. The latent period is typically proxied by the time from infection until an 127 infected person has virus shedding that is detectable by PCR, and can be shorter than the 128 incubation period for some COVID-19 cases when virus shedding becomes detectable prior 129 to symptom onset. The serial interval, defined as the time interval between successive 130 symptom onsets in a transmission chain, is an important parameter for estimating many other 131 key epidemiological parameters, such as R 0 , the expected number of secondary cases 132 generated from one primary case in a completely susceptible population, and the 133 instantaneous reproduction number (R t ) which describes the expected number of secondary 134 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted August 13, 2021. Close contacts were defined as individuals who were exposed to symptomatic COVID-19 144 cases within two days before their illness onset, or exposed to asymptomatic cases at close 145 proximity (<1 meter) without wearing proper personal protection equipment within two days 146 before their sampling dates of the first positive samples for SARS-CoV-2. Close contacts 147 were classified as household and extended family, social, community and healthcare contacts 148 based on the definitions previous published by Sun et al (10). Cases were considered having 149 effective 1-dose vaccination if the start date of exposure was 10 days after the first dose of 150 vaccination or later, or having effective 2-dose vaccination if the start date of exposure was 151 14 days after the second dose of vaccination or later (11, 12) . 152 153

We used a maximum likelihood-based inferential method to estimate the distributions of 155 latent period, incubation period and serial interval and the infectiousness profile of confirmed 156 COVID-19 cases by fitting Gamma distributions. We accounted for the interval censoring of 157 exposure and viral shedding windows when estimating the latent period and incubation 158 period distributions. To estimate the infectiousness profile for symptomatic cases, we used a 159 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101/2021.08.12.21261991 doi: medRxiv preprint 8 method previously published by He et al. (7) which considered the serial interval as a 160 convolution between the infectiousness profile and the incubation period and allowed for an 161 early occurrence of infectiousness before symptom onset. 162

The time-varying forward serial intervals (13, 14) and daily numbers of cases were used to 164 estimate the daily R t by applying the statistical methods developed by Cori et al (15). The 165 serial interval distribution and R 0 were obtained by using mean estimates of the serial interval 166 and R t during the exponential growth phase of the Delta outbreak (14). CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101/2021.08.12.21261991 doi: medRxiv preprint 9 of close contacts. To assess the effectiveness of vaccination against transmission, a stepwise 185 logistic regression model was fitted by including age, sex, disease severity of the index, 186 COVID-19 vaccination for index cases, COVID-19 vaccination for close contacts, type of 187 contact, presence of exposure on the symptom onsets of index cases and duration of exposure. 188

Non-parametric and parametric bootstrap approach with 1000 resamples was used to assess 189 the uncertainty of each estimated parameter. Analyses were carried out using R version 4.0. Figure 1A ). The mean incubation period estimated from 95 symptomatic Delta 205 cases was 5.8 days (95% CI: 5.2, 6.4). The 95 th percentile of the incubation period for Delta 206 was 11.5 days (95% CI: 10.1, 13.0) ( Figure 1B) . 207 208 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101/2021.08.12.21261991 doi: medRxiv preprint

We used data from 94 transmission pairs of Delta cases with a reported onset date to estimate 209 the infectiousness profile by allowing for transmission before symptom onset. We estimated 210 that 2.7% (95% CI: 1.0%, 5.0%) of transmission occurred prior to 7 days before illness onset, 211 22.5% (95% CI: 16.0%, 30.0%) started to become infectious 4 days before illness onset, and 212 the infectiousness peaked at 2.1 days (95% CI: 1.5, 2.7) before onset and then dropped 213 gradually, with 73.9% (95% CI: 67.2%, 81.3%) of transmission occurred before illness onset 214 and 97.1% (95% CI: 94.4%, 99.0%) of transmission occurred within 4 days after illness onset 215 ( Figure 1C) . 216 217 The estimated forward serial intervals decreased from 6.1 days (95% CI: 5.2, 7.1) on 25 May 218 2021 to 4.0 days (95% CI: 3.1, 5.0) on 18 June 2021 in the Delta outbreak ( Figure 2B ). By 219 using the time varying forward serial intervals and case incidence data, we estimated that the 220 R t dropped rapidly from 9.3 (95% CI: 7.7, 11.6) on 25 May 2021 to 0.48 (95% CI: 0.42, 0.57) 221 on 18 June 2021, and had been below 1 since 9 June 2021 ( Figure 2C ). During the same time 222 period, the estimated infectiousness peak shifted from 0.23 days (95% CI: 0.20, 0.26) after 223 illness onset to 2.14 days (95% CI: 1.52, 2.70) before illness onset based on the time varying 224 serial interval ( Figure 2D ). By using the daily estimates of forward serial interval and R t 225 during the exponential growth phase before 27 May 2021, the initial forward serial interval 226 was estimated to be 5.8 days (95% CI: 5.2, 6.1) ( Figure 2B ), and the R 0 was 6.4 (95% CI: 3.7, 227 9.3) ( Figure 2C ). 228 229 In total, 1314 throat swabs collected between 4 days before and 34 days after illness onset 230 were tested for 159 Delta cases. High viral loads were maintained between 4 days before 231 onset and 7 days after onset, then decreased gradually to a low but detectable level until about 232

Day 20 ( Figure 3A) . To compare viral loads between Delta and wild-type, we identified 94 233 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101/2021.08.12.21261991 doi: medRxiv preprint

Our study provided a comprehensive assessment of the epidemiological characteristics of the 258 Delta variant. Higher transmissibility was demonstrated for the Delta variant, as indicated by 259 a higher reproduction number, shorter latent and incubation periods, and shorter serial 260 intervals compared to the wild-type SARS-CoV-2 (5, 13, 16-18). We observed higher viral 261 loads in cases infected with the Delta variant which might contribute to more rapid and 262 intense transmission. In addition, we found the inactivated vaccines could effectively reduce 263 viral loads in cases infected with the Delta variant and further lead to lower transmissibility. 264

We estimated the time varying forward serial intervals which considered the temporal 266 dynamics of the disease transmission in an outbreak (13, 14) . The R 0 estimated for the Delta 267 variant was 6.4 which was substantially higher than the R 0 of the wild-type virus at the start 268 of the pandemic (16, 19) . Estimation of the reproduction number could be underestimated 269 due to unobserved infections and neglecting the changes in the forward serial interval 270 distribution during the period of epidemic (14). In the Delta outbreak in China, active and 271 aggressive case-finding strategies using multiple PCR tests were implemented, which was 272 able to identify most infected persons including asymptomatic cases. With the shorter latent 273 and incubation period, and higher secondary attack rate among household and extended 274 family contacts, we believe multiple and more stringent interventions are needed to control 275 epidemics of the Delta variant. During the Delta outbreak in China, the local government had 276 implemented individual-based interventions such as case isolation, contact tracing and 277 quarantine, as well as population-level physical distancing measures such as lockdowns and 278 confinement (10, 13). More importantly, various community-wide PCR testing and routine 279 testing programmes among quarantined close contacts were aligned with the measures of 280 contact tracing and lockdown, aiming to identify and isolate the cases as early as possible and 281 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101/2021.08.12.21261991 doi: medRxiv preprint 13 interrupt transmission chains. The rapid drop in R t within a week ( Figure 2C ) indicated the 282 effectiveness of these interventions. 283

We estimated that the 73.9% of transmissions occurred pre-symptomatically for the Delta 285 variant, which was higher than other variants (7, 20, 21), suggesting a higher transmission 286 potential of Delta cases before detection which was further supported by the high viral loads 287 at least 4 days before illness onset shown in our study. The high risk of transmission 288 particularly before onset indicated the need to expand contact tracing to a wider group of 289 contacts and perhaps to a longer time scale in order to control the epidemic caused by the 290 Delta variant (7, 22). However, for areas with a high prevalence of COVID-19, complete 291 contact tracing and quarantine outside the home may be infeasible as the number of contacts 292 is always several folds the number of infections (10). Physical distancing such as self-293 isolation and home quarantine is more suitable in these areas. However, society-wide 294 physical distancing measures might increase transmission risk at household settings (10, 20) . 295

Our study showed that the secondary attack rate (22.0%) among household close contacts of 296 Delta cases was higher than the rate obtained in 2020 (12.4%) in the same location with wild-297 type infections (23). 298

We found that the viral load was higher in cases of the Delta variant than cases of the wild-300 type virus, indicating a potentially higher infection rate per contact for the Delta (24). In 301 addition, patients infected with the Delta variant maintained a high viral load from 4 days 302 before illness onset. Besides, compared to the wild type, patients infected with Delta had a 303 slower decline in viral load towards the detection threshold of the PCR test ( Figure 3B) , 304 likely leading to a longer infectious period (24). Escape of the Delta variant from immunity 305 induced by wild-type variants (25) suggests that the herd immunity threshold needed to 306 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 14 suppress transmission of the wild-type virus may not be sufficient to control spread of the 307 Delta variant (24). Higher burden of SARS-CoV-2 is expected in the future given the 308 increasing predominance of the Delta variant all over the world. Additional booster doses of 309 vaccination might be able to increase protection against the Delta variant. Our study had several limitations. Self-reported symptom onset might bias estimates of the 324 parameters, e.g., leading to an overestimation of the incubation period if patients tended to 325 remember the later days with symptoms. Second, the Ct values used in our study were 326 obtained from different diagnostic kits which shared the same detection threshold but perhaps 327 with different sensitivity and/or specificity. Finally, in estimation of the serial interval, 328 transmission pairs with asymptomatic cases would be excluded due to absence of symptom 329 onset dates, which however might have biased the estimates of the reproduction number by 330 neglecting the impact of asymptomatic transmission. 331 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 In conclusion, the Delta variant demonstrated a higher transmissibility compared to the wild 333 type of SARS-CoV-2. An extension of contact tracing period to perhaps four days prior to 334 symptom onset may be needed considering the high proportion of pre-symptomatic 335 transmission and the high viral load before onset in infections with the Delta variant. 336

Inactivated vaccines appeared to be effective in reducing transmission of Delta infections and 337 a high vaccination coverage should be pursued to reduce the burden of COVID-19 pandemic. 338 339 340 341 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 

The authors thank Julie Au for technical support. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 a IQR: interquartile range b first COVID-19 vaccine dose 10 days before the first day of possible exposure to an infector c second COVID-19 vaccine dose was given 14 days before the first day of possible exposure to an infector d close contacts were exposed to an index at the time of the onset day of the index . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101/2021.08.12.21261991 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101/2021.08.12.21261991 doi: medRxiv preprint 23 relative to the date of illness onset. The data for the Delta variant excluded severe, critical and vaccinated cases. (C) Boxplot of the predicted Ct values from the multivariate GAMs for unvaccinated (red) and vaccinated (blue, with one or two doses) cases.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted August 13, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101/2021.08.12.21261991 doi: medRxiv preprint

Accessed 10

Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly 364

Genome Characterization 367 of the First Outbreak of COVID-19 Delta Variant B.1.617.2 -Guangzhou City

The Spike 370 Proteins of SARS-CoV-2 B.1.617 and B.1.618 Variants Identified in India Provide Partial 371

Resistance to Vaccine-elicited and Therapeutic Monoclonal Antibodies

Viral infection and Transmission in a 374 large well-traced outbreak caused by the Delta SARS-CoV-2 variant

Comprehensive large-scale nucleic 377 acid-testing strategies support China's sustained containment of COVID-19

Temporal dynamics in viral 380 shedding and transmissibility of COVID-19

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101 /2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted August 13, 2021. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted August 13, 2021. ; https://doi.org/10.1101/2021.08.12.21261991 doi: medRxiv preprint